Immune and Genetic Changes Linked to Laryngeal Cancer Development
Studies immune and genetic changes in adults with precancerous voice box cells.
Plain-language title generated from the registry record
Registry title: Role of the Immune System in Preventing Laryngeal Cancer
Key facts
- Where
- Milan, ItalySee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Source: NCT07508319, who can take part
Where in Italy
- European Institute of OncologyMilan, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- European Institute of Oncology
- Trial code
- NCT07508319
- Record updated
- 2 April 2026
- Original description
Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformationRead full original descriptionShow less
Laryngeal Dysplasia and Progression to Carcinoma: Investigating Genetic and Immune Alterations Predictive of Malignant Transformation
Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformation
Inclusion: Histopathological diagnosis of laryngeal dysplasia; Age >18 years and informed consent.
Exclusion: Prior surgical, radiotherapeutic, or oncologic treatments for head and neck regions; Immunosuppressive therapy; Congenital or acquired immunodeficiency disorders; Synchronous malignancies; Age <18 years or absence of research consent.